Michelina Cairo
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Peptidase Inhibition and Analysis, Advanced Breast Cancer Therapies, DNA Repair Mechanisms
Most-Cited Works
- → Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study(2021)67 cited
- → Decreased TGFβ signaling and increased COX2 expression in high risk women with increased mammographic breast density(2009)65 cited
- → Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP)(2024)28 cited
- → A BRCA1-Like, 25-Gene Assay Predicts for Anthracycline-Chemosensitivity in Sporadic Triple-Negative Breast Cancer.(2009)4 cited
- → Abstract PD3-08: Tucatinib vs placebo in combination with trastuzumab and capecitabine for patients with locally advanced unresectable or HER2-positive metastatic breast cancer (HER2CLIMB): Outcomes by hormone receptor status(2021)4 cited
- → Decreased TGFβ signaling and increased COX2 expression in high risk women with increased mammographic breast density.(2009)1 cited
- → Distinct molecular profiles of interval and screen-detected tumors in a real-world breast cancer registry.(2020)
- → Molecular portraits of mammographic breast density in normal breast tissue(2008)